 Orgenesis Inc announced a new collaboration with biotech firm Savicell Diagnostics Ltd to accelerate the development and manufacturing of its cell and gene therapy platform. The wide-ranging agreement sees Orgenesis using Savicells immunometabolism platform to help advance its own platforms on a number of fronts. 